In order to bring you the best possible user experience, this site uses Javascript. If you are seeing this message, it is likely that the Javascript option in your browser is disabled. For optimal viewing of this site, please ensure that Javascript is enabled for your browser.
Did you know that your browser is out of date? To get the best experience using our website we recommend that you upgrade to a newer version. Learn more.
 

B-Adrenergic Receptor Blockers (Expert Consensus Document on)

ESC Clinical Practice Guidelines

Coronary Artery Disease (Chronic)
Treatment
Treatment
Hypertension
Pharmacology and Pharmacotherapy
Treatment
Cardiovascular Pharmacotherapy
Acute Coronary Syndromes
Guidelines version available to download
Full text
Published in 2004
Reference European Heart Journal (2004) 25, 1341–1362; 10.1016/j.ehj.2004.06.002
Endorsed by cardiac societies
Belgian Society of Cardiology , Bulgarian Society of Cardiology , Czech Society of Cardiology , Estonian Society of Cardiology , French Society of Cardiology , German Cardiac Society , Israel Heart Society , Italian Federation of Cardiology , Netherlands Society of Cardiology , Romanian Society of Cardiology , San Marino Society of Cardiology , Slovak Society of Cardiology , Spanish Society of Cardiology , Swedish Society of Cardiology , Swiss Society of Cardiology , Turkish Society of Cardiology
Table of contents: Full Text (ESC Clinical Practice Guidelines)

Pharmacology

  • Definition
  • Classification of b-blockers
  • Pharmacokinetic properties: Lipophilic drugs, Hydrophilic drugs, Balanced clearance drugs
  • Mechanism of action
  • Adverse events: Cardiovascular, Metabolic, Pulmonary, Central effects, Sexual dysfunction
  • Contraindications
  • Drug interactions
  • Dosing of b-blockers

Clinical efficacy and use

  • Acute myocardial infarction (AMI)
  • Secondary prevention after myocardial infarction
  • Non-ST-segment elevation acute coronary syndromes
  • Chronic, stable ischaemic heart disease
  • Heart failure: Heart failure and preserved systolic function, Acute heart failure
  • Arrhythmias: Sinus tachycardia, Supraventricular tachycardias, Tachycardias in WPW syndrome, Atrial flutter, Atrial fibrillation, Ventricular arrhythmias
  • Prevention of sudden cardiac death: Acute myocardial infarction, Heart failure, Dilated cardiomyopathy, Hypertrophic cardiomyopathy, Mitral valve prolapse, Myocardial bridging, Long QT syndrome (LQTS), Catecholaminergic polymorphic ventricular tachycardia, SCD in the normal heart, Other situations

Hypertension

Aortic dissection

Hypertrophic cardiomyopathy

Prophylactic use in non-cardiac surgery

Vasovagal syncope

b-Blockers during pregnancy


 

 

 
About the ESC
Press and Media
Information
Follow us

         

 Contact us

© 2020 European Society of Cardiology. All rights reserved.